Refractory or Relapsed B Cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory or Relapsed B Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma (NCT05776407) | Chongqing University Cancer Hospital | 2023-05-01 |
Track Refractory or Relapsed B Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.